224 related articles for article (PubMed ID: 29767230)
1. Competing endogenous RNA regulatory network in papillary thyroid carcinoma.
Chen S; Fan X; Gu H; Zhang L; Zhao W
Mol Med Rep; 2018 Jul; 18(1):695-704. PubMed ID: 29767230
[TBL] [Abstract][Full Text] [Related]
2. Signature microRNAs and long noncoding RNAs in laryngeal cancer recurrence identified using a competing endogenous RNA network.
Tang Z; Wei G; Zhang L; Xu Z
Mol Med Rep; 2019 Jun; 19(6):4806-4818. PubMed ID: 31059106
[TBL] [Abstract][Full Text] [Related]
3. Network-based meta-analysis in the identification of biomarkers for papillary thyroid cancer.
Zhao H; Li H
Gene; 2018 Jun; 661():160-168. PubMed ID: 29625265
[TBL] [Abstract][Full Text] [Related]
4. The Landscape of Circular RNA Expression Profiles in Papillary Thyroid Carcinoma Based on RNA Sequencing.
Lan X; Xu J; Chen C; Zheng C; Wang J; Cao J; Zhu X; Ge M
Cell Physiol Biochem; 2018; 47(3):1122-1132. PubMed ID: 29847813
[TBL] [Abstract][Full Text] [Related]
5. Five genes involved in circular RNA-associated competitive endogenous RNA network correlates with metastasis in papillary thyroid carcinoma.
Qiu J; Sun M; Zang C; Jiang L; Qin Z; Sun Y; Liu M; Zhang W
Math Biosci Eng; 2021 Oct; 18(6):9016-9032. PubMed ID: 34814333
[TBL] [Abstract][Full Text] [Related]
6. Key genes and pathways predicted in papillary thyroid carcinoma based on bioinformatics analysis.
Yu J; Mai W; Cui Y; Kong L
J Endocrinol Invest; 2016 Nov; 39(11):1285-1293. PubMed ID: 27250077
[TBL] [Abstract][Full Text] [Related]
7. Construction and investigation of lncRNA-associated ceRNA regulatory network in papillary thyroid cancer.
Zhao Y; Wang H; Wu C; Yan M; Wu H; Wang J; Yang X; Shao Q
Oncol Rep; 2018 Mar; 39(3):1197-1206. PubMed ID: 29328463
[TBL] [Abstract][Full Text] [Related]
8. Molecular Network-Based Identification of Circular RNA-Associated ceRNA Network in Papillary Thyroid Cancer.
Liu Q; Pan LZ; Hu M; Ma JY
Pathol Oncol Res; 2020 Apr; 26(2):1293-1299. PubMed ID: 31289996
[TBL] [Abstract][Full Text] [Related]
9. Identification of potential biomarkers and drugs for papillary thyroid cancer based on gene expression profile analysis.
Qu T; Li YP; Li XH; Chen Y
Mol Med Rep; 2016 Dec; 14(6):5041-5048. PubMed ID: 27779685
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of miR‑486‑5p in papillary thyroid carcinoma tissue: A study based on microarray and miRNA sequencing.
Wen DY; Pan DH; Lin P; Mo QY; Wei YP; Luo YH; Chen G; He Y; Chen JQ; Yang H
Mol Med Rep; 2018 Sep; 18(3):2631-2642. PubMed ID: 30015845
[TBL] [Abstract][Full Text] [Related]
11. Investigating the mechanisms of papillary thyroid carcinoma using transcriptome analysis.
Qiu J; Zhang W; Xia Q; Liu F; Zhao S; Zhang K; Chen M; Zang C; Ge R; Liang D; Sun Y
Mol Med Rep; 2017 Nov; 16(5):5954-5964. PubMed ID: 28849102
[TBL] [Abstract][Full Text] [Related]
12. Integrated analysis identifying new lncRNA markers revealed in ceRNA network for tumor recurrence in papillary thyroid carcinoma and build of nomogram.
Chen F; Li Z; Deng C; Yan H
J Cell Biochem; 2019 Dec; 120(12):19673-19683. PubMed ID: 31271223
[TBL] [Abstract][Full Text] [Related]
13. BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis.
Zhang C; Bo C; Guo L; Yu P; Miao S; Gu X
World J Surg Oncol; 2019 Dec; 17(1):221. PubMed ID: 31842912
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of a set of microRNA genes reveals the potential mechanism of papillary thyroid carcinoma.
Feng Z; Song Y; Qian J; Chen T; Yang C; Jia L; Liu C; Liu P; Lv J; Deng Z
Ann Endocrinol (Paris); 2019 Apr; 80(2):77-83. PubMed ID: 30685058
[TBL] [Abstract][Full Text] [Related]
15. TCGA dataset‑based construction and integrated analysis of aberrantly expressed long non‑coding RNA mediated competing endogenous RNA network in gastric cancer.
He W; Zhang D; Li X; Wu J; Yang X; Wang Q; Lu W; Jiang J; Wu C
Oncol Rep; 2018 Dec; 40(6):3511-3522. PubMed ID: 30272352
[TBL] [Abstract][Full Text] [Related]
16. Identification and analysis of genes associated with papillary thyroid carcinoma by bioinformatics methods.
Zhang S; Wang Q; Han Q; Han H; Lu P
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30872410
[TBL] [Abstract][Full Text] [Related]
17. Special role of JUN in papillary thyroid carcinoma based on bioinformatics analysis.
Chen W; Liu Q; Lv Y; Xu D; Chen W; Yu J
World J Surg Oncol; 2017 Jul; 15(1):119. PubMed ID: 28673327
[TBL] [Abstract][Full Text] [Related]
18. Microarray technology to investigate genes associated with papillary thyroid carcinoma.
Zhu X; Yao J; Tian W
Mol Med Rep; 2015 May; 11(5):3729-33. PubMed ID: 25586635
[TBL] [Abstract][Full Text] [Related]
19. Integrated bioinformatics analysis reveals that the expression of cathepsin S is associated with lymph node metastasis and poor prognosis in papillary thyroid cancer.
Tan J; Qian X; Song B; An X; Cai T; Zuo Z; Ding D; Lu Y; Li H
Oncol Rep; 2018 Jul; 40(1):111-122. PubMed ID: 29749483
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA circZFR contributes to papillary thyroid cancer cell proliferation and invasion by sponging miR-1261 and facilitating C8orf4 expression.
Wei H; Pan L; Tao D; Li R
Biochem Biophys Res Commun; 2018 Sep; 503(1):56-61. PubMed ID: 29842886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
